31.05.2023 17:30:07

EQS-NVR: Heidelberg Pharma AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Total Voting Rights Announcement: Heidelberg Pharma AG / Total Voting Rights Announcement
Heidelberg Pharma AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

31.05.2023 / 17:30 CET/CEST
Total Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 31.5.2023
  Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
46599597



31.05.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com

 
End of News EQS News Service

1642989  31.05.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1642989&application_name=news&site_id=smarthouse

Analysen zu Heidelberg Pharma AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Heidelberg Pharma AG 2,33 4,02% Heidelberg Pharma AG